Moreover, Liao et al. reported that AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways [31]. Here, CXCR4 is linked to osteosarcoma.